Yale study identifies risk factors for older patients’ disability post-surgery

Fear of losing independence due to potential disability or poor functional outcome post-surgery is a primary concern for older people undergoing major surgery.

Yale faculty discuss the impacts of mass incarceration on health

Almost half of the American population has an immediate family member who was formerly or is currently incarcerated.

Yale researchers uncover the true mechanism of common diabetes drug

A new study by Yale researchers at the School of Medicine disproves previously held theories about the mechanism of metformin, one of the most effective medications to treat diabetes.

Yale global health researchers evaluate Ethiopia Primary Healthcare Transformation Initiative

Researchers at the Yale School of Public Health published a paper describing how the Ethiopia Primary Healthcare Transformation Initiative is improving primary healthcare system performance.

Yale study details method to increase accuracy and safety of CRISPR gene editing

The Glazer Lab at Yale has published a study discussing the possibility of increasing the accuracy and safety of CRISPR-Cas9 gene editing through the use of peptide nucleic acids.

As two-year anniversary of first COVID-19 admission at YNHH approaches, health system launches new initiatives

In a press conference on March 8, YNHH leaders updated the public on recent COVID-19 statistics, the hospital purchase proposal and their donation plan to support Ukraine.

Sen. Murphy participates in medical school misinformation roundtable

Senator Chris Murphy heard from members of Connecticut and the Yale community on how to best fight medical misinformation.

Robots and working-age mortality: Yale researcher explores health impacts of automation

A recent study revealed the relationship between automation and U.S. working-age mortality, demonstrating how the introduction of industrial robots impacted workers’ economic opportunity and health.

Yale researchers study ketamine as a potential treatment for depression in patients with Parkinson’s disease

A clinical study examining the effects of ketamine as a treatment for depression in patients with Parkinson’s disease is currently underway at Yale New Haven Hospital.

Yale researchers discover gene that drives breast cancer metastasis

A group of Yale researchers, led by Qin Yan, discovered that mutations in the gene CECR2 drive the progression and metastasis of breast cancer by suppressing the immune system.

Yale professor explains high rates of metabolic disease in developing world

A Yale economics professor, Kaivan Munshi, uses the intersection of economics and biology to account for high rates of metabolic disease in the developing world. He found a threshold income rate at which metabolic disease prevalence rapidly increases.